Harvey Capital Management Trimmed Novartis Ag (NVS) Position; Leucadia National Has Lifted Hess (HES) Position

Novartis AG (NYSE:NVS) Logo

Leucadia National Corp increased Hess Corp (HES) stake by 271.1% reported in 2018Q4 SEC filing. Leucadia National Corp acquired 96,051 shares as Hess Corp (HES)’s stock rose 9.81%. The Leucadia National Corp holds 131,481 shares with $5.33 million value, up from 35,430 last quarter. Hess Corp now has $19.39 billion valuation. The stock increased 1.61% or $1.01 during the last trading session, reaching $63.91. About 66,353 shares traded. Hess Corporation (NYSE:HES) has risen 29.91% since May 14, 2018 and is uptrending. It has outperformed by 25.54% the S&P500. Some Historical HES News: 08/03/2018 – Hess Sets Another Buyback, Winning Peace with Activist Investor–Update; 26/04/2018 – HESS CORP – TO ACQUIRE A 15 PERCENT PARTICIPATING INTEREST IN KAIETEUR BLOCK, OFFSHORE GUYANA; 29/05/2018 – Richland Source: Sullivan joins Whitcomb & Hess; 25/04/2018 – Hess Corp 1Q-End Cash, Cash Equivalents $3.7B; 25/04/2018 – HESS COO GREG HILL SPEAKS ON EARNINGS CONFERENCE CALL; 25/04/2018 – Hess Corp 1Q Upstream Capital, Exploratory Expenditures $384M; 26/04/2018 – HESS CORP – SUBSIDIARY REACHED AGREEMENT WITH ESSO EXPLORATION AND PRODUCTION GUYANA LIMITED TO ACQUIRE INTEREST IN KAIETEUR BLOCK; 25/04/2018 – HESS CORP – EXPLORATION & PRODUCTION CAPITAL AND EXPLORATORY EXPENDITURES WERE $384 MLN IN QUARTER, COMPARED TO $393 MLN IN PRIOR-YEAR QUARTER; 24/04/2018 – HESS CORP HES.N : JP MORGAN RAISES TARGET PRICE TO $51 FROM $49; 23/04/2018 – HESS CORP HES.N : SIMMONS RAISES TARGET PRICE TO $58 FROM $52

Harvey Capital Management Inc decreased Novartis Ag (NVS) stake by 47.06% reported in 2018Q4 SEC filing. Harvey Capital Management Inc sold 10,000 shares as Novartis Ag (NVS)’s stock declined 0.59%. The Harvey Capital Management Inc holds 11,250 shares with $965,000 value, down from 21,250 last quarter. Novartis Ag now has $188.90B valuation. The stock increased 0.26% or $0.21 during the last trading session, reaching $80.72. About 128,989 shares traded. Novartis AG (NYSE:NVS) has risen 8.33% since May 14, 2018 and is uptrending. It has outperformed by 3.96% the S&P500. Some Historical NVS News: 28/03/2018 – New top 10!~ Elephants can’t jump? IDEA’s Mike Rea says some Big Pharma players are crushing old beliefs @ideapharma $AZN $PFE $NVS; 22/03/2018 – NOVARTIS NOVN.S SAYS PLANS TO FILE MULTIPLE SCLEROSIS DRUG BAF312 FOR U.S. APPROVAL WITHIN WEEKS; 21/03/2018 – FDA: New Drug Application (NDA): 018281 Company: NOVARTIS; 12/03/2018 – Novartis: Shannon Klinger Named Chief Ethics, Risk and Compliance Officer; 16/05/2018 – NOVARTIS AG NOVN.S CEO SAYS BELIEVES CAN RESOLVE ISSUES SURROUNDING U.S. NEGATIVE DECISION ON RIXATHON BIOSIMILAR FOR MABTHERA; 18/05/2018 – Novartis, Amgen: Aimovig Is Migraine Prevention Drug; 14/05/2018 – Barbara: Exclusive: Novartis investigating $85 million bribery allegations in Turkey; 01/05/2018 – Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r; 19/04/2018 – $NVS CEO Vas Narasimhan found his replacement as development chief — at $AMGN John Tsai –; 27/03/2018 – Investors cheer GSK-Novartis deal

More notable recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis vows to fight Sandoz price-fixing claims – Seeking Alpha” on May 13, 2019, also Seekingalpha.com with their article: “Teva: Tarred And Feathered – Seeking Alpha” published on May 14, 2019, Seekingalpha.com published: “Novartis eyeing Takeda eye disease unit – Bloomberg – Novartis AG (NYSE:NVS) – Seeking Alpha” on May 08, 2019. More interesting news about Novartis AG (NYSE:NVS) were released by: Seekingalpha.com and their article: “Novartis Q1 2019 Earnings Preview – Seeking Alpha” published on April 23, 2019 as well as Benzinga.com‘s news article titled: “Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Fall (NYSE:TEVA)(NYSE:PFE)(NYSE:NVS)(NASDAQ:MYL) – Benzinga” with publication date: May 13, 2019.

Analysts await Novartis AG (NYSE:NVS) to report earnings on July, 17. They expect $1.20 earnings per share, down 4.76% or $0.06 from last year’s $1.26 per share. NVS’s profit will be $2.81 billion for 16.82 P/E if the $1.20 EPS becomes a reality. After $1.20 actual earnings per share reported by Novartis AG for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 3 analysts covering Novartis (NYSE:NVS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Novartis had 8 analyst reports since November 19, 2018 according to SRatingsIntel. As per Monday, November 19, the company rating was upgraded by Goldman Sachs. The stock of Novartis AG (NYSE:NVS) has “Buy” rating given on Tuesday, December 11 by Jefferies. The firm has “Outperform” rating by Cowen & Co given on Monday, November 26.

Among 5 analysts covering Hess (NYSE:HES), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Hess had 10 analyst reports since November 20, 2018 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Monday, March 11 with “Buy”. The firm earned “Hold” rating on Friday, March 15 by Citigroup. The firm has “Buy” rating given on Wednesday, March 20 by Societe Generale. On Tuesday, November 20 the stock rating was maintained by Morgan Stanley with “Overweight”. Barclays Capital upgraded Hess Corporation (NYSE:HES) on Thursday, January 10 to “Overweight” rating.

Investors sentiment is 0.92 in 2018 Q4. Its the same as in 2018Q3. It is the same, as 65 investors sold HES shares while 141 reduced holdings. only 56 funds opened positions while 134 raised stakes. 243.19 million shares or 6.74% more from 227.84 million shares in 2018Q3 were reported. Winslow Evans Crocker stated it has 0% in Hess Corporation (NYSE:HES). Ameritas Investment Prns Incorporated has 0.01% invested in Hess Corporation (NYSE:HES) for 4,442 shares. Factory Mutual Co invested in 590,100 shares. Weiss Asset LP has 0.52% invested in Hess Corporation (NYSE:HES) for 183,200 shares. Captrust Fincl reported 0% in Hess Corporation (NYSE:HES). 13,025 were accumulated by Pub Sector Pension Investment Board. 19,775 are owned by Corecommodity Management Ltd. Investec Asset, United Kingdom-based fund reported 1.96M shares. Oppenheimer & Inc invested in 6,917 shares. Mercer Cap Advisers accumulated 0.12% or 4,050 shares. Mirae Asset Invests Ltd accumulated 71,277 shares or 0.03% of the stock. Lord Abbett Co Ltd has 368,100 shares. Central Corporation, New York-based fund reported 700,000 shares. Wilen Invest Corp has invested 0.35% in Hess Corporation (NYSE:HES). Assetmark stated it has 1,446 shares.

More notable recent Hess Corporation (NYSE:HES) news were published by: Investorplace.com which released: “Buy ConocoPhillips Stock Following Its Beat on Earnings, Revenue – Investorplace.com” on May 05, 2019, also Fool.com with their article: “This Red-Hot Oil Stock Delivered Surprisingly Good Numbers in Q1 – Motley Fool” published on April 25, 2019, Seekingalpha.com published: “Guyana’s latest discovery similar to nearby Liza, Hess says – Seeking Alpha” on April 25, 2019. More interesting news about Hess Corporation (NYSE:HES) were released by: Seekingalpha.com and their article: “Hess Corp. Is Turning Around – Seeking Alpha” published on May 01, 2019 as well as Investorplace.com‘s news article titled: “4 Energy Stocks Soaring as Trump Tightens on Iran – Investorplace.com” with publication date: April 23, 2019.

Hess Corporation (NYSE:HES) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.